Dr. Robert D. Lewis, M.D. LLC Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4139 Boardman Canfield Rd, Suite 2, Canfield, OH 44406 Phone: 330-533-6999 Fax: 330-533-5498 |
Dr. Yau Too Chiu Jr., MD. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3768 Boardman Canfield Rd, Canfield, OH 44406 Phone: 330-533-2382 Fax: 330-533-1033 |
News Archive
Diet and lifestyle may play a much more significant role in a person's ability to respond favourably to certain drugs, including some cancer therapies, than previously understood, say scientists.
Psychiatric disorders can be described on many levels, the most traditional of which are subjective descriptions of the experience of being depressed and the use of rating scales that quantify depressive symptoms. Over the past two decades, research has developed other strategies for describing the biological underpinnings of depression, including volumetric brain measurements using magnetic resonance imaging (MRI) and the patterns of gene expression in white blood cells.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the ulcerative colitis drug market will nearly double from $1.2 billion in 2008 to $2.1 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
This is the conclusion of a recent population-wide study from Denmark, which demonstrates a "significant and immediate" spike in the diagnoses of trauma and stressor related disorders (e.g. adjustment disorders or post-traumatic stress disorder) in Denmark in the weeks and months after the traumatic events of September 11, 2001, even though the Nordic country was not directly impacted by the attacks.
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to recently released results from a clinical trial run by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Amylyx Pharmaceuticals, Inc., the company that manufactures the medication.
› Verified 7 days ago